into Phase 3 for corneal edema secondary to corneal endothelial disease during the second half of 2025. Aurion will have access to the broader R&D, regulatory, medical ophthalmic and commercial ...

or atopic keratoconjunctivitis (AKC), the mechanisms are more complex and probably involve both IgE and T-cell-mediated responses. Only the last two diseases develop corneal complications (Table 1).

Within the context of GDD implantation, suboptimal tissue compatibility is manifest in an array of complications including early fibrinous occlusion, corneal endothelial failure, tube migration, ...

Ophthalmology Times - ophthalmology news, articles, and events in a timely and accurate manner for members of the ophthalmic ...

ADHD-related TikTok content shapes viewer perceptions of the condition, but experts found that the videos often make inaccurate claims regarding symptoms and treatment, according to a study ...

The primary pathological mechanisms driving DME include increased vascular permeability and leakage, with vascular endothelial growth factor (VEGF ... The exclusion criteria included: (a) a history of ...

过氧化物酶体增殖物激活受体（PPAR）是一种核激素受体，主要参与脂质代谢。 最近的研究表明 PPAR 激动剂发挥血管保护作用。 本研究旨在表征内皮细胞中 PPAR- 基因失活的小鼠的血管功能。 使用loxP/Cre技术产生血管内皮细胞特异性PPAR基因缺失的小鼠（ePPAR/小鼠 ...